We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management

By LabMedica International staff writers
Posted on 17 Dec 2024

Millions of individuals with diabetes monitor their glucose levels daily using finger-stick devices that draw and analyze blood. More...

But imagine if this could be done with just a sweat sensor. This is the concept behind new research that could change diabetes management by eliminating the discomfort and inconvenience of traditional methods.

Traditional glucose monitoring systems use enzymatic reactions with blood samples, but these methods are not shelf-stable, making them difficult to store and ship. The self-replicating properties of bacteria, however, offer a potential solution. Researchers at Binghamton University (New York, NY, USA) have developed a new paper-based biosensor system that uses Bacillus subtilis bacterial spores, which germinate in response to glucose in potassium-rich fluids like sweat. The power generated by the spores indicates the glucose level, and the system can withstand harsh environments, activating only when the right conditions are met. This novel approach could transform diabetes management by eliminating the need for painful finger-stick blood samples.

The research team had previously used paper as a platform to create detectors for lead ions in seawater. Their earlier work also includes integrating biobatteries into 3D-printed circuits, creating devices that generate moisture from the air, and designing self-powered mechanical bugs for collecting ocean data. In light of the current global energy crisis, using bacteria to generate power presents a promising, sustainable solution. Since the biosensor is paper-based and disposable, it is cost-effective and simple to use. After publishing their findings in the journal Microsystems & Nanoengineering, the researchers are now working on refining the detection process further.

“Everyone has a different potassium concentration in their sweat, and I don’t know how this concentration affects the glucose,” said Professor Seokheun “Sean” Choi, who adapted the knowledge of biobatteries gained in his Bioelectronics and Microsystems Lab over the past 15 years to build the paper-based biosensor system. “The sensitivity also is lower than conventional enzymatic biosensors. But from this work, we created a new sensing mechanism to detect glucose. No one has done that yet.”


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.